News

Air pollution and health in Italy: analysis of time trends 1990-2019 from GBD 2019 estimates

Air pollution is one of the risk factors assessed by the Global Burden of Disease Study and is of great importance in population health. It actually ranks fourth in terms of impact on a global scale. Since it is known that air quality in Italy has peculiar criticalities, especially in the Po Valley area, we evaluated how the impact estimated by the GBD for our peninsula has varied over time, from 1990 to 2019, with regard to two specific pollutants: atmospheric particulate matter ≤2.5μm...

read more

How to arrive prepared for future pandemics?

In a recent episode of IHME's "Global Health Insights," Joseph Dieleman, professor of Health Metrics Sciences at IHME, and Thomas Bollyky, director of the Council on Foreign Relations (CFR) Global Health program, discuss how to arrive prepared for the next pandemic. The conversation revolves around the findings of an article published in The Lancet, which explores possible contextual factors associated with variability in COVID-19 infection and mortality in the different countries observed....

read more

IRCCS Neurologico Mediterraneo in Pozzilli joins signatories of agreement

We are happy and honored to welcome IRCCS Neurologico Mediterraneo of Pozzilli (IS) among the signatories of the collaboration agreement for the development and implementation of the Global Burden of Disease project in Italy. With IRCCS Neuromed, there are now 20 research institutions involved in the Agreement, a consolidating national network whose goal is to make the estimates generated under the Global Burden of Disease Study increasingly adherent to the Italian and global reality and...

read more

Redistribution of garbage codes to underlying causes of death: a systematic analysis on Italy and a comparison with the most populous Western European countries based on the Global Burden of Disease Study 2019

One of the main tasks of our network is to compare official Italian data with the corresponding estimates generated by the GBD study. This comparison is not always easy. GBD estimates of causes of death in Italy, for example, show several differences when compared with official data. These differences, however, have a reason to exist. Italy, despite being among the countries with the best current data and, specifically, the best data on causes of death, nevertheless produces about 25 percent...

read more

The Lancet: one in eight deaths in 2019 associated with bacterial infections, the second leading cause of death globally

On November 21, 2022, a recent IHME paper was published in The Lancet to present the results of an analysis of the burden of antimicrobial resistance (AMR) and bacterial pathogens and its impact on health globally. The work is part of a global initiative, Global Research on Antimicrobial Resistance (GRAM) project - implemented in collaboration with the University of Oxford - that brings together researchers from around the world to develop the evidence base for understanding the threat of...

read more

Disability in children and adolescents

Through the analysis of data from the 2019 Global Burden of Disease Study, we aimed to both provide prevalence and years lived with disabilities (YLDs) estimates for the diseases most represented in various age groups of the Italian population under the age of 20 in 2019, such as low back pain, headache, anxiety, and depression, and to propose evidence-based interventions to improve the health of younger people. It emerged how low back pain, whose YLDs amount to 6.3% in individuals under 20...

read more

Mental health in young people in Europe: Global Burden of Disease Study 1990-2019

Young people's mental health is a major public health concern in European youth, with major differences in resource allocation across EU and Schengen countries. Estimates derived from the Global Burden of Disease (GBD) Study 2019 provided information on the status of mental health (mental disorders, substance use disorders, and self-harm) in people aged 10-24 years in 31 European countries and changes in prevalence, incidence, Years Lived with Disability (YLDs), and Years of Life Lost (YLLs)...

read more

Cancer in Italy, 1990-2017: a systematic analysis of Global Burden of Disease 2017 data

Using data from the Global Burden of Disease Study 2017, we tracked Italy cancers in 2017 and trends for this disease over the past three decades. Specifically, we provided estimates of incidence (number of cases diagnosed per year), mortality (number of deaths per year), years of life lost due to premature death (YLL), years lived with disability (YLD), and years of life lost due to disability or premature death (disability-adjusted life-years, DALYs) for all cancers overall and for 30...

read more

In memory of Ettore Beghi

We find ourselves very sadly bidding a final farewell to Ettore Beghi. We would like to express all respect and admiration for the man and the researcher, and gratitude for his contribution to the birth and development of the Italian network of Global Burden of Disease researchers. Ettore co-founded the group, which has been present since the first initiative: the Venice workshop organized by Giancarlo Logroscino in October 2016 at the Congress of Neurology. His great experience and...

read more

Neurological diseases from 1990 to 2019: a systematic analysis of Global Burden of Disease 2019 estimates

Neurological diseases constitute a heterogeneous group of conditions that, at the population level, are widespread and disabling. Some of them have their onset after the age of 60-65, and considering the aging of the Italian population, it is highly likely that there will be an increasing trend in the prevalence of these diseases in our country. In this study, we used estimates on Italy for the years 1990 and 2019 to assess the incidence (i.e., the number of new cases per year), prevalence...

read more